CBD and Recurrent Pericarditis: What the Phase II MAvERIC-Pilot Trial Shows
CBD recurrent pericarditis findings come from a new Phase II trial of pharmaceutical CBD (CardiolRx). Twenty-seven patients saw pain scores drop and inflammation markers normalize over eight weeks. The open-label, industry-funded design means a…
CED Cannabis Science Digest: 3 Psychosis and Craving Signals Worth Watching
cannabis science digest July 12 2026: this digest preserves three verified mental-health and cannabis-use-disorder signals on sex-specific psychosis vulnerability, cannabis craving profiles, and EEG changes in cannabis use disorder. The takeaway is…
Progesterone for Cannabis Use Disorder: What the New Stress-Response Trial Actually Found
A July 2026 trial on progesterone cannabis use disorder research found it reduced stress-linked craving in females. The study was brief and focused on laboratory stress responses. It highlights the need for sex-specific research in cannabis use disorder…
Cannabis for Tourette Syndrome: What a New Meta-Analysis Really Shows
A 2026 meta-analysis pooled 306 adults with Tourette syndrome across seven studies and found cannabis-based medicines significantly reduced tic severity. Dr. Caplan breaks down what the evidence does and does not show.
High-Dose CBD for Neuropathic Pain: New RCT Explained
A new randomized, double-blind, placebo-controlled trial found high-dose CBD reduced neuropathic pain after spinal cord injury by about 14% versus 6.5% for placebo. Dr. Caplan reviews the evidence, the study's real limitations, and what it does and does…
Edibles vs Smoking: Which Cannabis Method Is Right for You?
Smoking and vaporizing act in minutes but fade in hours; edibles take longer to kick in but last far longer. Here's the physiology behind choosing between them, and what to try if edibles don't work for you.
CED Cannabis Science Digest: Pregnancy Risk Perception Signals
This digest highlights pregnancy safety beliefs cannabis signals from recent studies. It covers U.S. survey data on pregnancy risk perception and cannabis use trends among women of childbearing age. Additionally, it examines cannabis expectancies among…
Prenatal Cannabis Exposure and Neurodevelopment: What the New Systematic Review Actually Shows
A July 4, 2026 systematic review examined prenatal cannabis neurodevelopment impact, finding no consistent global cognitive impairment but more behavioral and attention difficulties. The evidence supports cautious counseling during pregnancy. This review…
Cannabis for PTSD: What 26 Studies and 3,598 Patients Actually Show
A new scoping review of 26 studies and 3,598 patients found that cannabis-based interventions mostly failed to outperform placebo for PTSD. The one exception was narrow: a synthetic cannabinoid that reduced nightmares. Here is what the evidence actually…
CED Cannabis Science Digest: 3 CUD, Dosing, and Neurobiology Signals Worth Watching
This digest presents 2026 cannabis use disorder research focusing on three key signals: cannabis use disorder recovery biology, THC pharmacokinetic variability, and cannabinoid neurobiology. The included studies provide educational insights without…